horse; endothelin-1; in vitro; pulmonary artery; bronchus; functional studies
Abstract :
[en] Reasons for performing study: There is currently little published information about the effects of endothelin-1 (ET-1), a potent endogenous spasmogen of vascular and airway smooth muscle, on pulmonary vasculature and airways or which ET receptor subtypes mediate ET-1 induced vasoconstrictive and bronchoconstrictive action in the horse.
Objectives: To investigate the effect of endothelin-1 (ET-1) on smooth muscle from isolated equine pulmonary artery and bronchus. In addition, the roles of ETA and ETB receptors in ET-1 mediated contraction in these tissues were assessed.
Methods: The force generation of ring segments from pulmonary arteries or third-generation airways (obtained from horses subjected to euthanasia for orthopaedic reasons) were studied in an organ bath at 37°C in response to exogenous endothelin and selective endothelin A (BQ123) or B receptor (BQ788) antagonists.
Results: ET-1 produced concentration-dependent contractions of the equine pulmonary artery and bronchus. The threshold for contraction was 10-10 and 10-9 mol/l ET-1 for pulmonary artery and bronchus, respectively. The maximal contraction induced by the highest ET-1 concentration (10-7 mol/l) was 173 and 194% of the contraction obtained with 100 mmol/l KCl in pulmonary artery and bronchus, respectively. ET-1 potency was 25 times greater in equine pulmonary artery than in equine bronchus (concentration of ET-1 producing 50% of maximal contraction [EC50] = 5.6 10-9 mol/l and 2.2 10-8 mol/l, respectively). In pulmonary artery, ET-1 induced contractions were significantly inhibited by the ETA receptor antagonist BQ123 (1 μmol/l; dose-response curve to ET-1 was shifted to the right by 5.4-fold), but not by the ETB antagonist BQ788. In bronchus, dose-responses curves to ET-1 were shifted to the right by BQ123 (1 μmol/l; 2.5-fold), but not by BQ788 (1 μmol/l). In the presence of both antagonists, the dose-response curve to ET-1 was shifted to the right by 4.5-fold.
Conclusions: These functional studies demonstrate that ET-1 is a potent spasmogen of equine third generation pulmonary artery and bronchus, and that contractions are mediated via ETA receptors in the former and both ETA and ETB receptors in the latter.
Potential clinical relevance: Endothelin receptor antagonists may have potential for treating equine pulmonary hypertension or bronchoconstriction.
Disciplines :
Veterinary medicine & animal health
Author, co-author :
Benamou, A. E. M.; Université de Liège - ULiège > Faculty of Veterinary Medicine > Physiology
Marlin, D. J.; Centre of Equine Studies Animal Health UK
Callingham, B. C.; University of Cambridge > Pharmacology
Hiley, R. C.; University of Cambridge > Pharmacology
Lekeux, Pierre ; Université de Liège - ULiège > Faculty of Veterinary Medicine > Physiology
Language :
English
Title :
Spasmogenic action of endothelin-1 on isolated equine pulmonary artery and bronchus
Publication date :
2003
Journal title :
Equine Veterinary Journal
ISSN :
0425-1644
eISSN :
2042-3306
Publisher :
Equine Veterinary Journal Ltd, Newmarket Suffolk, United Kingdom
Ahlborg, G. and Lundberg, J. (1997) Nitric oxide-endothelin-1 interaction in humans. J. appl. Physiol. 82, 1593-1600.
Advenier, C., Sarria, B., Naline, E., Puybasset, L. and Lagente, V. (1990) Contractile activity of three endothelins (ET-1, ET-2, ET-3) on the human isolated bronchus. Br. J. Pharmacol. 100, 168-172.
Barnes, P.J. (1998) Chronic obstructive pulmonary disease: new opportunities for drug development. Trends Pharmacol. Sci. 19, 415-423.
Barnes, P.J. and Liu, S.F. (1995) Regulation of pulmonary vascular tone. Pharmacol Rev. 47, 87-131.
Battistini, B. and Dussault, P. (1998) Blocking of the endothelin system: the development of receptor antagonists. Pulm. Pharmacol. Ther. 11, 97-112.
Battisitni, B., Warner, T.D., Fournier, A. and Vane, J.R. (1994) Characterization of ETB receptors mediating contractions induced by endothelin-1 or IRL1620 in guinea pig isolated airways: effects of BQ123, FR139317 or PD145065. Br. J. Pharmacol. 111, 1009-1016.
Baxter, G.M. (1995) Alterations of endothelium-dependent digital vascular responses in horses given low-dose endotoxin. Vet. Surg. 24, 87-96.
Benamou, A.E., Art, T., Marlin, D.J., Roberts, C.A. and Lekeux, P. (1999) Effect of exercise on concentrations of immunoreactive endothelin in bronchoalveolar lavage fluid of normal horses and horses with chronic obstructive pulmonary disease. Equine vet. J., Suppl. 30, 92-95.
Benamou, A.E., Marlin, D.J. and Lekeux, P. (2001a) Equine pulmonary and systemic haemodynamic responses to endothelin-1 and a selective ET(A) receptor antagonist. Equine vet. J. 33, 337-344.
Benamou, A.E., Marlin, D.J. and Lekeux, P. (2001b) Endothelin in the equine hypoxic pulmonary vasoconstrictive response to acute hypoxia. Equine vet. J. 33, 345-353.
Benamou, A.E., Art, T., Marlin, D.J., Roberts, C.A. and Lekeux, P. (1998) Variations in systemic and pulmonary endothelin-1 in horses with recurrent airway obstruction (heaves). Pulm. Pharm. Ther. 11, 231-235.
Bonvallet, S.T., Oka M., Yano, M., Zamora, M.R., McMurtry, I.F. and Stelzner, T.J. (1993) BQ123, an ETA receptor antagonist, attenuates ET-1 induced vasoconstriction in rat pulmonary circulation. J. cardiovasc. Pharmacol. 22, 39-43.
Brink, C., Gillard, V., Roubert, P., Mencia-Huerta, J.M., Chabrier, P.E., Braquet, P. and Verley, J. (1991) Effects and specific binding sites of endothelin in human lung preparation. Pulm. Pharmacol. 4, 54-59.
Dar, A. (1992) An in vitro Study of Pulmonary Vascular Reactivity and Amine Oxidase Activity in the Horse. PhD Thesis, University of Cambridge. pp 39-54.
Filep, J.G., Battistini, B. and Sirois, P. (1993) Induction by endothelin-1 of epithelium-dependent relaxation of guinea-pig trachea in vitro: role for nitric oxide. Br. J. Pharmacol. 109, 637-644.
Fukuroda, T., Nishikibe, M., Ohta, Y., Ihara, M., Yano, M., Ishikawa, K., Fukami, T. and Ikemoto, F. (1992) Analysis of responses to endothelins in isolated porcine blood vessels by using a novel endothelin antagonist BQ-153. Life Sci. 50, PL107-PL112.
Fukuroda, T., Kobayashi, M., Ozaki, S., Yano, M., Miyauchi, T., Onizuka, M., Sugishita, Y., Goto, K. and Nishikibe, M. (1994) Endothelin receptor subtypes in human versus rabbit pulmonary arteries. J. appl. Physiol. 76, 1976-1982.
Furchgott, R.F. and Vanhoutte, P.M. (1987) Endothelium-derived relaxing and contracting factors FASEB J. 3, 2007-2019.
Giaid, A., Yanagisawa, M., Langleben, D., Michel, R.P., Levy, R., Shennib, H., Kimura, S., Masaki, T., Duguid, W.P. and Stewart, D.J. (1993) Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N. Engl. J. Med. 328, 1732-1739.
Goldie, R.G., Grayson, P.S., Knott, P.J., Self, G.J. and Henry, P.J. (1994) Predominance of Endothelin A (ETA) receptors in ovine tracheal smooth muscle and their mediating of ET-1 induced contraction. Br. J. Pharmacol. 112, 749-756.
Goldie, R.G., D'aprile, A.C., Cvetkovski, R., Rigby, P.J. and Henry, P.J. (1996a) Influence of regional differences in ETA and ETB receptor subtype proportions on endothelin-1 induced contractions in porcine isolated trachea and bronchus. Br. J. Pharmacol. 117, 736-742.
Goldie, R.G., D'aprile, A.C. Self, G.J., Rigby, P.J. and Henry, P.J. (1996b) The distribution and density of receptor subtypes for endothelin-1 in peripheral lung of the rat, guinea pig and pig. Br. J. Pharmacol. 117, 729-735.
Hasunuma, K., Rodman, D.M., O'Brien, R.F. and McMurtry, I.F. (1990) Endothelin-1 causes pulmonary vasodilation in rats. Am J. Physiol. 258, H48-H54.
Hay, D.W.P., Henry, P.J. and Goldie, R.G. (1993a) Endothelin and the respiratory system. Trends Pharmacol. Sci. 14, 29-32.
Hay, D.W.P., Luttmann, M.A., Hubbard, W.C. and Undem, B.J. (1993b) Endothelin receptor subtypes in human and guinea pig pulmonary tissue. Br. J. Pharmacol. 110, 1175-1183.
Hay, D.W.P., Hubbard, W.C. and Undem, B.J. (1993c) Endothelin-induced contraction and mediator release in human bronchus. Br. J. Pharmacol. 110, 392-398.
Haynes, W.G. and Webb, D.J. (1998) Endothelin as a regulator of cardiovascular function in health and disease. J. Hypertens. 16, 1081-1098.
Henry, P.J., Rigby, P.J., Self, G.J., Preuss, J.M. and Goldie, R.G. (1990) Relationship between endothelin-1 binding site densities and constrictor activities in human and animal airway smooth muscle. Br. J. Pharmacol. 100, 786-792.
Hislop, A.A., Zhao, Y.D., Springall, D.R., Polak, J.M. and Haworth, S.G. (1995) Postnatal changes in endothelin-1 binding in porcine pulmonary vessels and airways. Am. J. Respir. Cell. mol. Biol. 12, 557-566.
Holm, P. and Franco-Cerreceda, A. (1996) Tissue concentrations of endothelins and functional effects in endothelin-receptor activation in human arteries and veins. J. Thorac. Cardiovasc. Surg. 112, 264-272.
Horsfield, K. (1978) Morphometry of small pulmonary arteries in man. Circulation 42, 593-597.
Ikemura, T., Ohmori, K., Tanaka, T., Matsuda, Y. and Kitamura, S. (1996) Effects of endothelin B antagonist RES-701-1 on endothelin-induced contractile responses in vivo and in vitro in guinea pigs. J. Pharm. Pharmacol 48, 100-105.
Jones, R.D. and Morice, A.H. (1998) The ETA antagonist CI-1020 inhibits hypoxic pulmonary vasoconstriction in small isolated rat pulmonary arteries. Pulm. Pharmacol. Ther. 11, 177-181.
Kauser, K., Rubanyi, G.M. and Harder, R. (1990) Endothelium-dependent modulation of endothelin-induced vasoconstriction and membrane depolarization in cat cerebral arteries. J. Pharmac. Exper. Therap. 252, 93-97.
La Douceur, D.M., Flynn, M.A., Keiser, J.A., Reynolds, E. and Haleen, S.J. (1993) ETA and ETB receptors coexist on rabbit pulmonary artery. Br. J. Pharmacol. 196, 209-215.
Le Blanc, P.H., Broadstone, R.V., Derksen, F.J. and Robinson, N.B. (1991) In vitro responses of distal airways in horses with recurrent airway obstruction. Am. J. Vet. Res. 52, 999-1003.
Maclean, M.R., McCulloch, K.M. and Baird, M. (1994) Endothelin ETA and ETB mediated vasoconstriction in rat pulmonary arteries and arterioles. J. cardiovasc. Pharmacol. 23, 838-845.
Maclean, M.R., Doherty, C.C., McCulloch, K.M. and Morecroft, I. (1998) Effect of novel ETA/ ETB antagonists on response to ET-1 in human small muscular pulmonary arteries. Pulm. Pharmacol. Ther. 11, 147-149.
MacEachern, K.E., Smith, G.L. and Nolan, A.M. (1997) Methods for the isolation, culture and characterisation of equine pulmonary artery endothelial cells. Res vet Sci. 62, 147-152.
Maggi, C.A., Patacchini, R., Giuliani, S. and Meli, A. (1989) Potent contractile effect of endothelin in isolated guinea-pig airways. Eur. J. Pharmacol. 160, 179-182.
Maggi, C.A., Giuliani, S., Patacchini, R., Santicioli, P., Giachetti, A. and Meli, A. (1990) Further studies on the response of the guinea pig isolated bronchus to endothelins and sarafatoxin S6b. Eur. J. Pharmacol. 176, 1-9.
McCulloch, K.M. and MacLean, M.R. (1995) Endothelin B receptor-mediated contraction of human and rat pulmonary resistance arteries and the effect of pulmonary hypertension on endothelin responses in the rat. J. cardiovasc. Pharmacol. 26, (Suppl. 3), S169-176.
McCulloch, K.M., Doherty, C.C. and MacLean, M.R. (1998) Endothelin receptors mediating contraction of rat and human pulmonary resistance arteries: effect of chronic hypoxia in the rat. Br. J. Pharmacol. 123, 1621-1630.
McKay, K.O., Black, J.L. and Armour, C.L. (1991) The mechanism of action of endothelin in human lung. Br. J. Pharmacol. 102, 422-428.
Moulds, R.F.W. (1983) Techniques for testing isolated blood vessels. Gen. Pharmacol. 14, 47:53.
Nagase, T., Aoki, T., Matsui, H., Oka, T., Fukuchi, Y. and Ouchi, Y. (1997) ET-1 induced bronchoconstriction is mediated via ETB receptor in mice. J. appl. Physiol. 83, 46-51.
Nakayama, K. (1988) Active and passive biomechanical properties of ring and spiral segments of isolated dogs basilar artery assessed by electrical and pharmacological stimulations. Blood Vessels 25, 285-298.
Naline, E., Devillier, P., Drapeau, G., Toty, L., Bakdach, H., Regoli, D. and Advenier, C. (1989) Characterization of neurokinin effects and receptor in human isolated bronchi. Am. Rev. resp. Dis. 140, 679-686.
Ninomiya, H., Uchida, Y., Saotome, M., Nomura, A., Ohse, H., Matsumoto, H., Hirata, F. and Hasegawa, S. (1992) Endothelins constrict guinea pig tracheas by multiple mechanisms. J. Pharmacol. Expt. Ther. 262, 570-576.
O'Donnell, S.R. and Kay, C.S. (1995) Effects of endothelin receptor selective antagonists BQ123 and BQ788, on IRL1620 and ET-1 responses of airway and vascular preparations from rats. Pulm. Pharmacol. 8, 11-19.
Olson, L.E., Perkowski, S.Z., Mason, D.E. and Muir, W.W. (1989) Epithelium and mucosa-dependent relaxatin and contracion of normal equine trachealis muscle. Am. J. vet. Res. 50, 1720-1724.
Perrault, T. and Baribeau, J. (1995) Characterization of endothelin receptors in newborn piglet lung. Am. J. Physiol. 268, L607-L614.
Redington, A.E., Springall, D.R., Ghatei, M.A., Lau, L.C., Bloom, S.R., Holgate, S.T., Polak, J.M. and Howarth, P.H. (1995) Endothelin in bronchoalveolar lavage fluid and its relation to airflow obstruction in asthma. Am. J. Respir. crit. Care Med. 151, 1034-1039
Rodman, D.M., McMurtry, I.F., Peach, J.L. and O'Brien, R.F. (1989) Comparative pharmacology of rat and porcine endothelin in rat aorta. Eur. J. Pharmacol. 165, 297-300.
Sofia, M., Mormile, M., Faraone, S., Alifano, M., Zofra, S., Romano, L. and Carratu, L. (1993) Increased endothelin-like immunoreactive material on bronchoalveolar lavage fluid from patients with bronchial asthma and patients with interstitial lung disease. Respiration 60, 89-95.
Springall, D.R., Howarth, P.H., Counihan, H, Djukanovic, R., Holgate, S.T. and Polak, J.M. (1991) Endothelin immunoreactivity of airway epithelium in asthmatic patients. Lancet 23, 337(8743), 697-701.
Stewart, D.J. (1993) Endothelin in cardiopulmonary disease: factor paracrine vs neurohumoral. Eur. Heart J. 14, Suppl. I, 48-54.
Tschirhart, E.J., Drijfhout, J.W., Pelton, J.T., Miller, R.C. and Jones, C.R. (1991) Endothelins: functional and autoradiographic studies in guinea-pig trachea. J. Pharmacol. expt. Ther. 258, 381-387.
Tippins, J.R., Antoniw, J.W. and Massed, A. (1989) Endothelin-1 is a potent constrictor in conductive and resistive coronary arteries. J. cardiovasc. Pharmacol. 13, Suppl. 5, S177-S179.
Toga, H., Ibe, B.O. and Usha Raj, J. (1992) In vitro responses of ovine intrapulmonary arteries and veins to endothelin-1. Am. J. Physiol. 263, L15-L21.
Turner, N.C., Power, R.F., Polak, J.M., Bloom, S.R. and Dollery, C.T. (1989) Endothelin induced contractions of tracheal smooth muscle and identification of specific endothelin binding sites in the trachea of the rat. Br. J. Pharmacol. 98, 361-366.
Vane, J.R., Anggard, E.E. and Bolting, R.M. (1990) Regulatory functions of the vascular endothelium. New Engl. J. Med. 323, 27-36.
Warner, T.D., De Nucci, G. and Vane, J.R. (1989) Rat endothelin is a vasodilator in the isolated perfused mesentery of the rat. Eur. J. Pharmacol. Sci. 159, 325-326.
White, S.R., Hathaway, D.P., Umans, J.G., Tallet J., Abrahams, P. and Leff, A.R. (1991) Epithelial modulation of airway smooth muscle response to endothelin-1. Am. Rev. respir. Dis. 144, 373-378.
Yanagisawa, M., Kurihara, H., Kimura, S., Tomobe, Y., Kobayashi, M., Mitsui, Y., Yazaki, Y., Goto, K. and Masaki, T. (1988) A novel potent vasoconstrictor peptide produced by endothelial cells. Nature Lond. 332, 411-415.